section name header

Pronunciation ⬇

peer-i-DOX-een

Classifications ⬆ ⬇

Therapeutic Classification: vitamins

Pharmacologic Classification: water soluble vitamins

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Required for amino acid, carbohydrate, and lipid metabolism.
  • Used in the transport of amino acids, formation of neurotransmitters, and synthesis of heme.
Therapeutic effects:
  • Prevention of pyridoxine deficiency.
  • Prevention or reversal of neuropathy associated with hydralazine, penicillamine, or isoniazid therapy.

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed from the GI tract.

Distribution: Stored in liver, muscle, and brain.

Metabolism/Excretion: Converted in RBCs to pyridoxal phosphate and another active metabolite. Amounts in excess of requirements are excreted unchanged by the kidneys.

Half-Life: 15–20 days.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
PO, IM, IVunknownunknownunknown

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Adverse reactions listed are seen with­­excessive doses only.

Neuro: sensory neuropathy, paresthesia

Misc: pyridoxine-dependency syndrome

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Prevention of Deficiency (Recommended Daily Allowance)

Treatment of Deficiency

Pyridoxine-Dependent Seizures

Drug-Induced Neuritis

Isoniazid Overdose (>10 g)

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Rate:

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Code ⬆

NDC Code